Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study.
about
Week 120 efficacy of tenofovir, lamivudine and lopinavir/r-based second-line antiretroviral therapy in treatment-experienced HIV patientsReasons and Risk Factors for the Initial Regimen Modification in Chinese Treatment-Naïve Patients with HIV Infection: A Retrospective Cohort AnalysisEffect of changing from first- to second-line antiretroviral therapy on renal function: a retrospective study based on data from a single health facility in Namibia.Increased bone resorption during tenofovir plus lopinavir/ritonavir therapy in Chinese individuals with HIVEfficacy and Safety of Tenofovir and Lamivudine in Combination with Efavirenz in Patients Co-infected with Human Immunodeficiency Virus and Hepatitis B Virus in China.Pharmacokinetics of tenofovir during pregnancy and postpartum.Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention.Steady-state pharmacokinetics of tenofovir disoproxil fumarate in human immunodeficiency virus-infected Chinese patients.Gaps in the Continuum of HIV Care: Long Pretreatment Waiting Time between HIV Diagnosis and Antiretroviral Therapy Initiation Leads to Poor Treatment Adherence and OutcomesAn investigation of the pattern of kidney injury in HIV-positive persons exposed to tenofovir disoproxil fumarate: an examination of a large population database (MHRA database).
P2860
Q28545183-D0CEF823-F540-4716-9C68-233C3E42F57AQ28546795-DB2968B3-DB18-452F-89A4-DF0A2910ED3EQ31108490-86E7C1E0-2D6D-4FC4-8BA7-8D508CE330F5Q35102114-F237C3BB-BF07-4758-B4D9-FD33A169B2DAQ36705583-F2B89F1F-0E7A-413A-908F-E4DD5FFD153AQ36888597-956F9A67-DF2F-467F-BE87-2B4D7172590CQ38222708-353C313C-6493-44A7-8796-066BE91F1327Q38798813-2976216D-CEA7-4262-999B-2D300AC536DEQ41860717-40D08EC3-2CBB-46D9-9EE5-80CEE6468F89Q45145750-428328B8-E1DD-4653-8479-33809B75AF98
P2860
Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Impact of a tenofovir disoprox ...... rospective, multicenter study.
@ast
Impact of a tenofovir disoprox ...... rospective, multicenter study.
@en
Impact of a tenofovir disoprox ...... rospective, multicenter study.
@nl
type
label
Impact of a tenofovir disoprox ...... rospective, multicenter study.
@ast
Impact of a tenofovir disoprox ...... rospective, multicenter study.
@en
Impact of a tenofovir disoprox ...... rospective, multicenter study.
@nl
prefLabel
Impact of a tenofovir disoprox ...... rospective, multicenter study.
@ast
Impact of a tenofovir disoprox ...... rospective, multicenter study.
@en
Impact of a tenofovir disoprox ...... rospective, multicenter study.
@nl
P2093
P2860
P356
P1476
Impact of a tenofovir disoprox ...... rospective, multicenter study.
@en
P2093
Lixia Zhang
Taisheng Li
Xiaojing Song
Yanling Li
P2860
P2888
P356
10.1186/1471-2334-13-301
P577
2013-07-01T00:00:00Z
P5875
P6179
1032725664